Health care stocks were mixed premarket Tuesday with the Health Care Select Sector SPDR Fund (XLV) down 1.2% and the iShares Biotechnology ETF (IBB) recently up 0.3%.
UnitedHealth Group (UNH) shares declined by over 9% after the company suspended its 2025 outlook and named Stephen Hemsley as chief executive, effective immediately, succeeding Andrew Witty.
CNS Pharmaceuticals (CNSP) shares surged by over 92% after the company said it has acquired from Cortice Biosciences orphan drug designation for late-stage abeotaxane TPI 287 as a potential treatment for glioblastoma multiforme.
Legend Biotech (LEGN) shares were up over 1% after the company reported a narrower Q1 adjusted net loss as revenue more than doubled during the period.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。